Peripheral CCL2-CCR2 signalling contributes to chronic headache-related sensitization

Abstract

Migraine, especially chronic migraine, is highly debilitating and still lacks effective treatment. The persistent headache arises from activation and sensitization of primary afferent neurons in the trigeminovascular pathway, but the underlying mechanisms remain incompletely understood. Animal studies indicate that signalling through chemokine C-C motif ligand 2 (CCL2) and C-C motif chemokine receptor 2 (CCR2) mediates the development of chronic pain after tissue or nerve injury. Some migraine patients had elevated CCL2 levels in CSF or cranial periosteum. However, whether the CCL2-CCR2 signalling pathway contributes to chronic migraine is not clear.

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 07, 2023
Source ID
10.1093/brain/awad191

Entities

People

  • Jintao Zhang
  • Sun Ryu
  • Tingting Guo
  • Xuemei Liu
  • Yu‐Qing Cao
  • Zhaohua Guo

Organizations

  • National Institutes of Health
  • United States Department of Defense
  • Washington University in St. Louis

Tags

Fields of Study

  • Medicine

Readers

  • Cellular and Molecular Pathways of Apoptosis.
  • Immunology
  • Neurotrauma and Rehabilitation Medicine.